India In-vitro Fertilization Services Market Outlook 2032
The India in-vitro fertilization (IVF) services market size was valued at $883.50 Million in 2022 and is estimated to surpass $4667.80 Million by 2032, exhibiting a CAGR of 18.08% from 2023-2032.
The in-vitro fertilization (IVF) refers to the specialized healthcare sector focused on assisted reproductive technologies (ART), used to help couples and individuals conceive a child. IVF involves the fertilization of an egg with sperm outside the human body in a laboratory setting. The process typically includes ovarian stimulation, egg retrieval, fertilization in a controlled environment, and embryo transfer into the uterus. IVF is utilized in cases of infertility, certain medical conditions, or for fertility preservation. The market encompasses various services, technologies, and equipment related to IVF procedures, such as pre-implantation genetic testing, cryopreservation, and specialized culture media. It addresses the growing demand for fertility treatments and supports individuals seeking to overcome reproductive challenges.
Market Dynamics
The India In-vitro fertilization services market is driven by several factors that contribute to its growth and development. Rise in the median age of first-time mothers drives the growth of the market. It is observed that, there has been a noticeable trend towards women delaying childbirth for various reasons, such as pursuing higher education, career advancement, and financial stability. As women age, their fertility declines, and the chances of natural conception decrease. This delay in starting a family has led to increase in demand for IVF treatments, as these technologies offer hope and options for achieving pregnancy even at an older age.
Furthermore, the increasing number of fertility clinics and the improving success rates of fertility treatments are significant drivers for the growth of the market. As the demand for fertility services rises, more clinics are entering the market to cater to the growing needs of individuals and couples seeking fertility treatments. Further, advancements in assisted reproductive technologies and continuous R&D contribute to higher success rates in fertility treatments. This includes improved embryo selection methods, better culture media, and enhanced techniques for cryopreservation, leading to higher chances of successful pregnancies.
Therefore, combination of these factors, including the rise in fertility clinics and the increasing success rates, creates a positive perception of fertility treatments among potential patients. As more individuals become aware of the higher chances of achieving pregnancy through these treatments, the demand for fertility services, especially IVF, continues to grow, thus driving the overall market expansion.
However, factors that restrain the market growth include complications related to IVF treatment, such as ovarian hyperstimulation syndrome, multiple pregnancies, ectopic pregnancies, and the risk of miscarriages. Furthermore, fertility drugs used during treatment may cause side effects, and egg retrieval can pose risks like bleeding or infection. Patients may experience emotional and physical stress, leading some to reconsider or avoid IVF. Negative experiences and reports of complications may also create apprehension among potential patients, reducing the demand for IVF services. These concerns and potential adverse outcomes present challenges for the growth and acceptance of IVF treatments.
During the COVID-19 pandemic, the India in-vitro fertilization (IVF) services market experienced a significant decline due to treatment suspensions and delays caused by safety concerns and travel restrictions. Organizations such as the American Society for Reproductive Medicine (ASRM) recommended the postponement of new fertility cycles and non-urgent procedures, leading to reduced footfall and disruptions in the supply chain for clinics. In addition, international patients were deterred from seeking treatment in countries including India.
However, post-COVID, there has been a notably increase in fertility clinics, thus driving the growth of the IVF services market. The pandemic highlighted the importance of reproductive health, creating heightened awareness and demand for fertility treatments. To cater to this growing need, more clinics are entering the market, especially in regions with limited access to IVF services.
Furthermore, clinics are adopting strategic measures, such as offering discounted prices for certain procedures, to gain a competitive edge and attract a larger patient base. By providing more affordable options, clinics aim to make IVF treatments accessible to a broader segment of the population and encourage more patients to consider and opt for IVF services.
As a result, the combination of increased clinic presence and patient-attracting strategies like discounted pricing is expected to boost the IVF services market during the forecast period. Also, advancements in technology, changes in regulations, and shifts in patient preferences are expected to play essential roles in shaping the future of the IVF industry.
Segmental Overview
The India in-vitro fertilization (IVF) services market is segmented on the basis of gender, procedure, cycle type, end user, and offering. By gender, it is divided into female infertility, male infertility, and others. By procedure, it is classified into intracytoplasmic sperm injection (ICSI-IVF), non-ICSI-IVF, and intrauterine insemination (IUI). By cycle type, the market is categorized into fresh cycle (non-donor), thawed cycle (non-donor), and donor egg IVF cycle. By end user, it is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. By offering, it is divided into IVF drugs, IVF media & reagents, and IVF and IUI services.
By Gender
The India in-vitro fertilization services market is segmented into female infertility and male infertility. The female infertility segment held the highest market share in terms of revenue in 2022 and is expected to maintain its dominance during the forecast period, owing to rising prevalence of female infertility and rise in numerous medical conditions ,such as fibroid development, endometriosis, polycystic ovarian syndrome, ovulation disorders, damage to the fallopian tubes and uterus, as well as complications associated with the cervix . However, the male infertility segment is expected to witness highest CAGRs during the forecast period, owing to advancements in diagnostic technologies. There have been significant improvements in diagnosing male infertility factors, leading to more precise and personalized treatment approaches for the treatment. Further, semen analysis, genetic testing, and specialized imaging techniques now play a crucial role in pinpointing specific male infertility issues, allowing clinicians to offer tailored treatment options. Moreover, lifestyle factors like smoking, excessive alcohol consumption, and sedentary habits are also recognized to have a notable impact on male fertility, thus driving the segment growth.
By Gender
Female Infertility segment held a dominant position in 2022 and is anticipated to grow at a fastest rate during the forecast period.
By Procedure
The India in-vitro fertilization services market is classified into intracytoplasmic sperm injection (ICSI-IVF), non-ICSI-IVF, and intrauterine insemination (IUI). The ICSI-IVF segment held the highest market share in terms of revenue in 2022 and is expected to maintain its dominance during the forecast period. The benefits of the ICSI-IVF technique are attributed to several factors. It allows for better fertilization outcomes since only one sperm and one egg is directly involved in the process, increasing the chances of successful fertilization. This targeted approach reduces the risk of multi-nucleation, a condition where multiple sperm enter the egg, which can negatively affect embryo development. In addition, ICSI-IVF bypasses the need for the acrosome reaction, which is a natural process in conventional IVF where the sperm must penetrate the egg's outer layer (zona pellucida). By directly injecting the sperm into the egg, this step is circumvented, which can be advantageous, especially in cases where the sperm may have difficulty penetrating the egg's outer layer.
However, the non-ICSI-IVF segment is expected to witness highest CAGRs during the forecast period, owing to its cost-effectiveness, thus the ICSI-IVF procedure has become a popular choice. However, advancements in embryo selection techniques and culture media have significantly improved the success rates of non-ICSI-IVF treatments as well. These developments have made non-ICSI-IVF a reliable and viable option for couples seeking to achieve successful pregnancies.
By Procedure
ICSI IVF segment held a dominant position in 2022 and is anticipated to grow at a fastest rate during the forecast period.
By Cycle Type
The India in-vitro fertilization services market is classified fresh cycle (non-donor), thawed cycle (non-donor), and donor egg IVF cycle. The fresh cycle segment held the highest market share in terms of revenue in 2022 and is expected to maintain its dominance during the forecast period, owing to enhanced success rates observed in fresh cycle IVF treatments. They have become more favored by couples seeking infertility solutions. Furthermore, fresh cycle IVF provides increased flexibility since it permits multiple attempts if the initial cycle is unsuccessful, without requiring additional expensive freezing and storage processes. However, the thawed cycle segment is expected to witness highest CAGRs during the forecast period, owing to the increasing adoption of cryopreservation techniques. These techniques offer several advantages, including flexibility, comparable success rates, cost-effectiveness, and the ability to preserve fertility. As a result, more and more individuals and couples are opting for this approach, contributing to its expanding popularity.
By End User
The India in-vitro fertilization services market is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes. The fertility clinics segment held the highest market share in terms of revenue in 2022 and is expected to maintain its dominance during the forecast period. This is attributed to the availability of multiple fertility clinics. In addition, fertility clinics are specialized centers equipped with advanced technology and skilled medical professionals, offering a comprehensive range of fertility services, including in vitro fertilization (IVF), intrauterine insemination (IUI), egg freezing, and gamete donation. Furthermore, the success rates of fertility clinics have also improved over the years due to advancements in technology and treatment protocols, thus boosting their reputation and attracting more patients.
By Offering
The India In-vitro fertilization services market is classified into IVF drugs, IVF media & reagents, and IVF and IUI services. The IVF and IUI services segment held the highest market share in terms of revenue in 2022 and is expected to maintain its dominance during the forecast period This is attributed to the rising adoption of IVF and IUI services, which has been driven by increase in infertility cases among both, men and women. In addition, the growing awareness and acceptance of assisted reproductive technologies (ART) has played a significant role in boosting the popularity of this segment. As more people become knowledgeable about these advanced fertility treatments and their notable success rates, the demand for IVF and IUI services has witnessed a substantial surge.
Competition Analysis
Competitive analysis and profiles of the major players in the India in-vitro fertilization services market such as Major players that operate in the market include Apollo Fertility, ART Fertility Clinics, Bavishi Fertility Institute, Bloom IVF Group, Craft Hospital & Research Centre, Dr. Thomas Fertility Center/Chennai Fertility Centers, Gunasheela Fertility Center, Indira IVF, Iswarya fertility Center, and Nova IVF Fertility. Key players have adopted strategy such as expansion to enhance their product portfolio.
Recent Expansion in India In-vitro fertilization Services Market
- In January 2021, Nova IVF Fertility, India’s leading fertility chain, announced the expansion of its network in NCR through a strategic partnership with Southend Fertility & IVF, a leading IVF player in Delhi NCR. Through this investment, the combined entity is expected to have a significant presence in Delhi NCR with a network of 4 comprehensive IVF centers including embryology labs, network of spoke centers, a team of senior IVF clinicians, and a capacity to perform more than 3500 IVF cycles annually in that region.
India In-vitro Fertilization Services Market Report Highlights
| Aspects | Details |
 By Gender |
|
 By Procedure |
|
 By Cycle Type |
|
 By End User |
|
 By Offering |
|
 By Key Market Players |
|
 Key Market Players | Gunasheela Fertility Center, Bloom Fertility Centre, Chennai Fertility Centre, ART Fertility Clinics, Morpheus Life Sciences Pvt. Ltd., Indira IVF Hospital Private Limited, Nova IVF Fertility, Craft Hospital & Research Centre, Iswarya Fertility Centers, Bavishi Fertility Institute |
Analyst Review
This section provides various opinions of top-level CXOs in the India in-vitro fertilization (IVF) services market. According to the insights of CXOs, the India in-vitro fertilization (IVF) services market presents several opportunities and challenges. The rise in infertile population and surge in fertility tourism in the region is potentially driving the market growth. Furthermore, the rise in medical conditions such as PCOS, fallopian tube obstruction and endometriosis that affect the fertility rate, are further anticipated to drive the market growth.
CXOs further stated that the increase in success rate of IVF, surge in disposable income, and rise in trend of delayed pregnancies further drive the market growth. Moreover, rise in technological advancements and growing awareness regarding the IVF procedures, significantly boost the growth of the India in-vitro fertilization (IVF) services market. However, complications associated with the use of IVF and inadequate reimbursement policies are expected to hinder the market growth. In addition, improved healthcare infrastructure, introduction of fertility programs, and enhanced access to diagnosis and treatment, contribute to the growing demand for the India IVF service market.
The total market value of India In-Vitro Fertilization (IVF) Services Marketis $0.8 billion in 2022.
The forecast period for India In-Vitro Fertilization (IVF) Services Market is 2023-2032.
The market value of India In-Vitro Fertilization (IVF) Services Market in 2032 is $4.6 billion.
The base year is 2022 in India In-Vitro Fertilization (IVF) Services Market
Major key players that operate in the India In-Vitro Fertilization (IVF) Services Market are Nova IVF Fertility, Bloom Fertility Centre, Indira IVF Hospital Private Limited, and ART Fertility Clinics.
The ICSI IVF segment is the most influencing segment in the India In-Vitro Fertilization (IVF) Services Market.This is attributed to benefits associated with ICSI-IVF technique such as better fertilization and minimization of multi-nucleation since only one sperm and one egg is involved in this technique as well as there is no acrosome reaction taking place in this technique.
The India In-Vitro Fertilization (IVF) Services Market growth is driven by an increase in infertility rates, technological advancements in IVF and rise in gamete donations .
In-vitro fertilization (IVF) process involves fertilization of egg cells by sperm outside the woman’s body and then implanting it in the uterus. It is a type of assisted reproductive technology (ART) based treatment, which is used to treat fertility or genetic problems to assist with conception of child.
Loading Table Of Content...
